Equities researchers at StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The firm has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- Which Wall Street Analysts are the Most Accurate?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What Are Treasury Bonds?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What Are the FAANG Stocks and Are They Good Investments?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
